Free Trial

Tonix Pharmaceuticals (TNXP) Stock Chart & Stock Price History

Tonix Pharmaceuticals logo
$7.30 +0.02 (+0.27%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$7.31 +0.01 (+0.14%)
As of 10/9/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tonix Pharmaceuticals Stock Price Performance

The Tonix Pharmaceuticals (TNXP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.55%, with a year-to-date return of -53.27%. In the past month, the stock has decreased 40.55%, reflecting recent market activity.

As of the latest close, Tonix Pharmaceuticals traded at $7.30 with a market cap of $125.20 million and volume of 960,892 shares. Five years ago, the stock traded at a split-adjusted price of $337,280.00, representing a 100.00% decrease over that period. At the time, it had a market cap of $188.41 million and a volume of 823 shares.

Receive TNXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-9.54%
1 Month
Performance
-40.55%
3 Month
Performance
-41.74%
Year-To-Date
Performance
-53.27%
1 Year
Performance
-65.55%
5 Year
Performance
-100.00%

TNXP Stock Chart for Saturday, October, 10, 2026

Tonix Pharmaceuticals Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/09/2026$7.28$7.30
+0.27%
$7.54$7.09960,892 shs$125.20 million
10/08/2026$7.55$7.28
-3.58%
$7.72$7.161.09 million shs$124.85 million
10/07/2026$7.70$7.55
-1.95%
$7.79$7.42708,026 shs$129.49 million
10/06/2026$8.07$7.70
-4.58%
$8.33$7.692.54 million shs$132.06 million
10/05/2026$8.91$8.07
-9.43%
$8.82$8.001.14 million shs$138.40 million
10/02/2026$9.23$8.91
-3.47%
$9.56$8.69802,578 shs$152.81 million
10/01/2026$9.74$9.23
-5.24%
$9.69$9.19474,950 shs$158.30 million
09/30/2026$9.65$9.74
+0.93%
$9.92$9.57317,459 shs$167.04 million
09/29/2026$9.90$9.65
-2.53%
$10.08$9.56393,584 shs$165.50 million
09/28/2026$9.86$9.90
+0.41%
$10.05$9.70342,238 shs$169.80 million
09/25/2026$9.70$9.86
+1.65%
$9.90$9.62378,268 shs$169.11 million
09/24/2026$10.24$9.70
-5.27%
$10.23$9.64613,263 shs$166.36 million
09/23/2026$10.59$10.24
-3.31%
$10.84$9.96913,516 shs$175.62 million
09/22/2026$10.72$10.59
-1.21%
$11.19$10.49584,684 shs$181.63 million
09/21/2026$10.87$10.72
-1.38%
$11.08$10.52523,781 shs$183.85 million
09/18/2026$11.42$10.87
-4.82%
$11.47$10.80807,907 shs$186.42 million
09/17/2026$11.76$11.42
-2.89%
$12.14$11.32388,745 shs$195.85 million
09/16/2026$11.62$11.76
+1.20%
$11.85$11.52273,675 shs$201.70 million
09/15/2026$11.73$11.62
-0.94%
$11.84$11.52288,313 shs$199.28 million
09/14/2026$11.87$11.73
-1.18%
$12.24$11.59454,046 shs$201.17 million
09/11/2026$12.28$11.87
-3.34%
$12.62$11.66512,459 shs$203.57 million
09/10/2026$12.83$12.28
-4.29%
$12.71$12.22287,042 shs$210.60 million

This page (NASDAQ:TNXP) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners